Zobrazeno 1 - 10
of 136
pro vyhledávání: '"Heike, Benes"'
Autor:
Kasper Recourt, Peter de Boer, Peter van der Ark, Heike Benes, Joop M. A. van Gerven, Marc Ceusters, Luc van Nueten, Wayne C. Drevets, Anindya Bhatacharya, Michael Browning, Gabriel E. Jacobs
Publikováno v:
Translational Psychiatry, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract JNJ-54175446 is a selective purine P2X7 receptor (P2X7R) antagonist that attenuates microglial IL-1β/IL-18 release. In healthy volunteers, JNJ-54175446 suppressed peripheral interleukin (IL)-1β release, and attenuated dexamphetamine-induce
Externí odkaz:
https://doaj.org/article/ce0f225410c64ac8b7a1ca0270900c52
Autor:
Yaroslav Winter, Geert Mayer, Sylvia Kotterba, Heike Benes, Lothar Burghaus, Andreas Koch, Daniela Girfoglio, Melinda Setanoians, Ulf Kallweit
Publikováno v:
Sleep Medicine. 103:138-143
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3dd3593b1e8cc19a8bd16e8fcf171a00
https://doi.org/10.1016/j.sleep.2023.01.022
https://doi.org/10.1016/j.sleep.2023.01.022
Autor:
Dieter Kunz, Yves Dauvilliers, Heike Benes, Diego García-Borreguero, Giuseppe Plazzi, Dalma Seboek Kinter, Preciosa Coloma, Magdalene Rausch, Mouna Sassi-Sayadi, Stephen Thein
Publikováno v:
CNS Drugs. 37:93-106
Daridorexant is a dual orexin receptor antagonist for the treatment of insomnia. In two phase III, 12-week studies in patients with insomnia disorder, daridorexant improved sleep and daytime functioning while maintaining a favorable safety profile. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01d24eb842f614aee35f2ba52fe727d8
https://doi.org/10.1007/s40263-022-00980-8
https://doi.org/10.1007/s40263-022-00980-8
Autor:
Yaroslav Winter, Geert Mayer, Sylvia Kotterba, Heike Benes, Lothar Burghaus, Gregory Parks, Andreas Koch, Daniela Girfoglio, Melinda Setanoians, Ulf Kallweit
Publikováno v:
Monday, April 24.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::053a703db2c5a373cc17804514911b3a
https://doi.org/10.1212/wnl.0000000000203940
https://doi.org/10.1212/wnl.0000000000203940
Autor:
Geert Mayer, Anna Heidbreder, Sylvia Kotterba, Magdolna Hornyak, Svenja Happe, Ulf Kallweit, Heike Benes
Publikováno v:
Nervenheilkunde. 40:550-557
ZUSAMMENFASSUNGDas Restless-legs-Syndrom (RLS) ist eine der häufigsten neurologischen Erkrankungen. Gutachterliche Fragestellungen bei RLS-Patienten nehmen seit den vergangenen Jahren stetig zu. Daher hat die AG Motorik und Schlaf der Deutschen Gese
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5ad5345cea05495de3f5a061e19bdc5
https://doi.org/10.1055/a-1389-6954
https://doi.org/10.1055/a-1389-6954
Autor:
Yaroslav Winter, Geert Mayer, Sylvia Kotterba, Heike Benes, Lothar Burghaus, Gregory Parks, Iresha Abeynayake, Pamela Romero-Cruz, Samantha Floam, Hannah Kwak, Ulf Kallweit
Publikováno v:
SLEEP. 46:A247-A247
Introduction Excessive daytime sleepiness (EDS) is a symptom of Obstructive Sleep Apnea (OSA) that can persist despite primary airway therapy and can be managed with wake-promoting agents. Solriamfetol (Sunosi®) is a wake-promoting agent approved to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bdb76e6586197b33c63cad54e445067d
https://doi.org/10.1093/sleep/zsad077.0561
https://doi.org/10.1093/sleep/zsad077.0561
Publikováno v:
The Patient
Background and Objective Chronic insomnia has major consequences for daytime functioning, yet no fully validated patient-reported outcome instrument for once-daily assessments is available to measure these consequences. This study describes the devel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06fba3bd9195bb0d423880de18639e51
https://doi.org/10.1007/s40271-020-00474-z
https://doi.org/10.1007/s40271-020-00474-z
Autor:
John D. Hudson, Richard K. Bogan, Heike Benes, Dan Chen, Thomas Stern, Lawrence Lee, Stephen G. Thein, Morgan Bron, Jed Black, Terri E. Weaver, Christopher L. Drake, James Maynard, James M. Andry, Lawrence P. Carter
Publikováno v:
Annals of the American Thoracic Society
Rationale: Excessive daytime sleepiness in patients with obstructive sleep apnea is associated with substantial burden of illness. Objectives: To assess treatment effects of solriamfetol, a dopamine/norepinephrine reuptake inhibitor, on daily functio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9a0f50d2d2649e5f7728919ad3284b7
https://doi.org/10.1513/annalsats.202002-136oc
https://doi.org/10.1513/annalsats.202002-136oc
Autor:
Ulf Kallweit, Yaroslav Winter, Sylvia Kotterba, Heike Benes, Lothar Burghaus, Andreas Koch, Daniela Girfoglio, Melinda Setanoians, Geert Mayer
Publikováno v:
Journal of Neurology, Neurosurgery & Psychiatry. 93:e2.234
IntroductionSolriamfetol is a dopamine/norepinephrine reuptake inhibitor approved in the EU for excessive daytime sleepiness (EDS) associated with narcolepsy. This real-world study characterises outcomes following solriamfetol initiation.MethodsSURWE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::799cdfccb6db67b028429dfa6c805a05
https://doi.org/10.1136/jnnp-2022-abn2.83
https://doi.org/10.1136/jnnp-2022-abn2.83
Publikováno v:
Clinical neurophysiology 132(1), 137-145 (2021). doi:10.1016/j.clinph.2020.10.019
Objective To evaluate the accuracy of actigraphy against polysomnography (PSG) as gold standard using a newly developed algorithm for sleep/wake discrimination that explicitly models the temporal structure of sleep. Methods PSG was recorded in 11 men
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e76f9d0ac3a9ac179127aa8cf99dbea3
https://pub.dzne.de/record/155684
https://pub.dzne.de/record/155684
